Addus Homecare
ADUS · NASDAQ
About ADUS
- Employees
- 5,290
- Headquarters
- Frisco, Texas
- Listed
- Oct 28, 2009
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- addus.com
ADUS key statistics
- Market cap
- 2.20B
- Price-earnings ratio
- 20.17
- Dividend yield
- —
- Average volume
- 188.34K
- Volume
- 138.99K
- Open price
- $116.09
- High today
- $118.18
- Low today
- $116.09
- 52 Week high
- $124.44
- 52 Week low
- $87.95
Addus Homecare (ADUS) at a glance
Addus Homecare (ADUS) last traded at $118.03, with a market cap of 2.20B and a price-to-earnings ratio of 20.17.
Today the stock has traded between $116.09 and $118.18. The current price is 1.7% above the day's low and 0.1% below its high.
Volume so far is 138.99K shares, below the average of 188.34K shares a day.
Over the past year Addus Homecare has ranged from $87.95 to $124.44, and now sits 82% of the way up that range.
Addus Homecare met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $1.73 per share against an estimate of $1.73.
The average analyst price target is $136.37, 15.5% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy57.1%
- Hold28.6%
- Sell14.3%
- Low
- $96.96
- Now
- $118.03
- High
- $162.75
ADUS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 2.0% on average.
- Q3 FY24: reported $1.30 per share against an estimate of $1.31
- Q4 FY24: reported $1.38 per share against an estimate of $1.37
- Q1 FY25: reported $1.42 per share against an estimate of $1.36
- Q2 FY25: reported $1.49 per share against an estimate of $1.50
- Q3 FY25: reported $1.56 per share against an estimate of $1.56
- Q4 FY25: reported $1.77 per share against an estimate of $1.76
- Q1 FY26: reported $1.62 per share against an estimate of $1.58
- Q2 FY26: reported $1.73 per share against an estimate of $1.73
ADUS news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
- Press releaseBusiness Wire
Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
- Press releaseBusiness Wire
Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis
- Press releaseBusiness Wire
Addus HomeCare Announces Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call
- Press releaseBusiness Wire
Addus HomeCare to Participate in Upcoming Investor Conferences in May
Addus HomeCare Q1 2026 Earnings Call: Complete Transcript
Similar companies
Companies in the same industry as Addus Homecare
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.